E. Malvolti

Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.

F. Johnson, K. Parhofer, A. Mohamed, 2013, Diabetes & metabolism.

COPD_A_215859 2959..2970

N. Zidouni, S. Amr, E. Malvolti, 2019 .

A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa

A. Albanna, R. V. van Zyl-Smit, N. Zidouni, 2019, International journal of chronic obstructive pulmonary disease.

Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study

B. Charbonnel, P. Piatti, T. Delibaşı, 2012, Current medical research and opinion.

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

L. Niskanen, M. Hanefeld, É. Hardy, 2015, Diabetes, obesity & metabolism.

PROPAGATION ABILITY OF SELECTED WALNUT HYBRIDS (JUGLANS REGIA L. × J. NIGRA L.)

F. Ducci, E. Malvolti, R. Proietti, 2005 .

Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.

K. Parhofer, C. Östgren, A. Mohamed, 2013, Diabetes & metabolism.